T2D@ZJU: a knowledgebase integrating heterogeneous connections associated with type 2 diabetes mellitus

Type 2 diabetes mellitus (T2D), affecting >90% of the diabetic patients, is one of the major threats to human health. A comprehensive understanding of the mechanisms of T2D at molecular level is essential to facilitate the related translational research. Here, we introduce a comprehensive and up-to-date knowledgebase for T2D, i.e. T2D@ZJU. T2D@ZJU contains three levels of heterogeneous connections associated with T2D, which is retrieved from pathway databases, protein–protein interaction databases and literature, respectively. In current release, T2D@ZJU contains 1078 T2D related entities such as proteins, protein complexes, drugs and others together with their corresponding relationships, which include 3069 manually curated connections, 14 893 protein–protein interactions and 26 716 relationships identified by text-mining technology. Moreover, T2D@ZJU provides a user-friendly web interface for users to browse and search data. A Cytoscape Web-based interactive network browser is available to visualize the corresponding network relationships between T2D-related entities. The functionality of T2D@ZJU is shown by means of several case studies. Database URL: http://tcm.zju.edu.cn/t2d

[1]  Zhenggang Yang,et al.  Regulation of Insulin and Leptin Signaling by Muscle Suppressor of Cytokine Signaling 3 (SOCS3) , 2012, PloS one.

[2]  K. Petersen,et al.  Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. , 2002, The Journal of clinical investigation.

[3]  F. Ashcroft,et al.  Diabetes Mellitus and the β Cell: The Last Ten Years , 2012, Cell.

[4]  J. Flier,et al.  SOCS3 Mediates Feedback Inhibition of the Leptin Receptor via Tyr985 * , 2000, The Journal of Biological Chemistry.

[5]  Gary D. Bader,et al.  Cytoscape Web: an interactive web-based network browser , 2010, Bioinform..

[6]  Nisha Kapoor,et al.  SOCS3 expression induced by PIM2 requires PKC and PI3K signaling. , 2009, Molecular immunology.

[7]  P. H. Wang,et al.  Polymorphism of HMGA1 is associated with increased risk of type 2 diabetes among Chinese individuals , 2012, Diabetologia.

[8]  Shuang Ma,et al.  Inhibition of SOCS-3 in adipocytes of rats with diet-induced obesity increases leptin-mediated fatty acid oxidation , 2009, Endocrine.

[9]  J. Shaw,et al.  IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. , 2011, Diabetes research and clinical practice.

[10]  Ben B Yaspelkis,et al.  High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKKalpha/beta phosphorylation and decreases PI-3 kinase activity in muscle. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[11]  Sofianos Andrikopoulos,et al.  Liver‐specific suppressor of cytokine signaling‐3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity 1 , 2010, Hepatology.

[12]  Christopher B. Newgard,et al.  Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.

[13]  Hung-Chou Kuo,et al.  Identification of Gene Networks and Pathways Associated with Guillain-Barré Syndrome , 2012, PloS one.

[14]  Hyun-Seok Jin,et al.  Type 2 diabetes genetic association database manually curated for the study design and odds ratio , 2010, BMC Medical Informatics Decis. Mak..

[15]  S. Agrawal,et al.  T2D-Db: An integrated platform to study the molecular basis of Type 2 diabetes , 2008, BMC Genomics.

[16]  M. Myers,et al.  Functional Role of Suppressor of Cytokine Signaling 3 Upregulation in Hypothalamic Leptin Resistance and Long-Term Energy Homeostasis , 2010, Diabetes.

[17]  A. Garg,et al.  HMGA1, a novel locus for type 2 diabetes mellitus. , 2011, JAMA.

[18]  Anushya Muruganujan,et al.  PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium , 2009, Nucleic Acids Res..

[19]  Susumu Goto,et al.  KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..

[20]  E. Van Obberghen,et al.  SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice* , 2001, The Journal of Biological Chemistry.

[21]  R. Norton,et al.  Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. , 2012, Immunity.

[22]  Adam D. Schuyler,et al.  SciMiner: web-based literature mining tool for target identification and functional enrichment analysis , 2009, Bioinform..

[23]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[24]  Ian A. Trounce,et al.  Deletion of Skeletal Muscle SOCS3 Prevents Insulin Resistance in Obesity , 2012, Diabetes.

[25]  Lincoln Stein,et al.  Reactome knowledgebase of human biological pathways and processes , 2008, Nucleic Acids Res..

[26]  M. K. C. Hesselink,et al.  Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus? , 2008, Diabetologia.

[27]  Michael Karin,et al.  Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.

[28]  N. M. van den Broek,et al.  Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes. , 2012, The Journal of clinical endocrinology and metabolism.

[29]  J. Flier,et al.  Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. , 2006, Diabetes.

[30]  Ian M. Donaldson,et al.  iRefIndex: A consolidated protein interaction database with provenance , 2008, BMC Bioinformatics.